• United Kingdom

Accepting PhD Students

1987 …2023
If you made any changes in Pure these will be visible here soon.

Personal profile

Personal Statement

I obtained a pharmacy degree from the University of Strathclyde in 1979 followed by a PhD in Physiochemical Aspects of Anti-Cancer Drug Targeting Systems in 1984. I worked during pre-registration in industrial and hospital pharmacy settings, joined SIPBS as a lecturer in 1984 and was appointed Director of the Formulation Unit in 1992. The Unit's role is to characterise, analyse, formulate and manufacture putative anti-cancer drugs accepted by CRUK's New Agents Committee for use in human clinical trials, where I have now been pharmaceutically responsible for over 20 novel NCE's. Arising from this are research interests, which include medicinal and analytical chemistry, drug physiochemistry, formulation for both small volume and parenteral and oral products and the GMP production of specialist pharmaceutical products for phase l clinical trials. The latter incorporates research areas such as microbiology and lyophilisation. In addition related research is conducted in drug targeting and delivery systems for cancer chemotherapy for example the utilisation of synthetic Low Density Lipoprotein systems. I have over £10 million in personal career grant income and over 150 published papers, conference abstracts and presentations.

Undergraduate teaching is limited due to the nature of the Formulation Unit's activities to introductory and specialist courses associated with the areas above applicable to undergraduate pharmacists. Since 1987 I have been involved in post qualification education teaching for the pharmaceutical industry and initiated and teach on the joint SIPBS-David Begg Associates Qualified Persons training course which has been running since 1991.

Fingerprint Dive into the research topics where Gavin Halbert is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 17 Similar Profiles
Pharmaceutical Preparations Medicine & Life Sciences
Solubility Medicine & Life Sciences
Excipients Medicine & Life Sciences
Dosage Forms Medicine & Life Sciences
Boron Neutron Capture Therapy Medicine & Life Sciences
Clinical Trials, Phase I Medicine & Life Sciences
Albendazole Medicine & Life Sciences
Mannitol Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2003 2023

Research Output 1987 2019

1 Citation (Scopus)

Characterisation and optimisation of diclofenac sodium orodispersible thin film formulation

Khadra, I., Obeid, M. A., Dunn, C., Watts, S., Halbert, G., Ford, S. & Mullen, A., 20 Apr 2019, In : International Journal of Pharmaceutics. 561, p. 43-46 4 p.

Research output: Contribution to journalArticle

Diclofenac
Water
Drug Delivery Systems
Pharmaceutical Preparations
Tooth
2 Citations (Scopus)
Extrusion
Printing
Fabrication
Chemical analysis
Pharmaceutical Preparations

Thesis

Development and control of pharmaceutical solids using extrusion and granulation

Author: Martinez Marcos, L., 1 Oct 2016

Supervisor: Halbert, G. (Supervisor) & (Supervisor)

Student thesis: Doctoral Thesis

In vitro and in silico profiling to assist pharmaceutical development

Author: Perrier, J. J., 1 Oct 2018

Supervisor: Halbert, G. (Supervisor) & Elliott, M. (Supervisor)

Student thesis: Doctoral Thesis

Activities 2008 2019

  • 3 Oral presentation
  • 1 Participation in conference
  • 1 Key-note speaker and plenary lectures at conferences
  • 1 Membership of committee

ToF-SIMS imaging of amorphous solid dispersions: a stability study

Eleonora Paladino (Speaker), Frederik Doerr (Contributor), Iyke I. Onyemelukwe (Contributor), Ian Gilmore (Contributor), Gavin Halbert (Contributor)
23 Oct 2019

Activity: Talk or presentation typesOral presentation

3D imaging of controlled-release electrospun material

Eleonora Paladino (Speaker), Ivan Hall Barrientos (Contributor), Frederik Doerr (Contributor), Dimitrios A. Lamprou (Contributor), Melissa Passarelli (Contributor), Gavin Halbert (Contributor)
12 Sep 2017

Activity: Talk or presentation typesOral presentation

Impacts

Improved health and survival rates for patients with malignant brain and prostate cancer, and economic benefit from new chemotherapy treatments.

Gavin Halbert (Participant)

Impact: Impact - for External PortalEconomic and commerce, Health and welfare - new products, guidelines and services

File